Simmen U, Bobirnac I, Ullmer C, Lübbert H, Berger Büter K, Schaffner W, et al. Antagonist effect of pseudohypericin at CRF1 receptors. Eur J Pharmacol. 2003;458:251-6 pubmed

Schempp C, Simon Haarhaus B, Simon J. Phototoxic and apoptosis-inducing capacity of pseudohypericin. Planta Med. 2002;68:171-3 pubmed

Denke A, Schempp H, Weiser D, Elstner E. Biochemical activities of extracts from Hypericum perforatum L. 5th communication: dopamine-beta-hydroxylase-product quantification by HPLC and inhibition by hypericins and flavonoids. Arzneimittelforschung. 2000;50:415-9 pubmed

Meruelo D, Lavie G, Lavie D. Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin. Proc Natl Acad Sci U S A. 1988;85:5230-4 pubmed

Takahashi I, Nakanishi S, Kobayashi E, Nakano H, Suzuki K, Tamaoki T. Hypericin and pseudohypericin specifically inhibit protein kinase C: possible relation to their antiretroviral activity. Biochem Biophys Res Commun. 1989;165:1207-12 pubmed

Lavie G, Valentine F, Levin B, Mazur Y, Gallo G, Lavie D, et al. Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin. Proc Natl Acad Sci U S A. 1989;86:5963-7 pubmed